Clonazepam has long been identified as among the best-recognized therapies for very long-expression neurological and psychiatric care on account of its precision mechanism of action, extensive fifty percent-lifetime and confirmed clinical trustworthiness. Its power to selectively bind to GABA-A receptors and stabilize hyperactive neural pathways ca